BioSpace: Realizing Gene Therapy and Cell Regeneration in Heart Disease

Jan 24, 2022
PDF Version

In this article from Gail Dutton, CEO Faraz Ali, MBA, explains the science and ideas behind our pipeline and why our candidates have the potential to help patients. Faraz details the diversity of our approaches and the thinking behind why we call ourselves a modality-agnostic company.

Read More

RSS Feeds
Email Alerts
Contact IR
Print